Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

Wouter Hoefsloot, Jakko van Ingen, Claire Andrejak, Kristian Ängeby, Rosine Bauriaud, Pascale Bemer, Natalie Beylis, Martin J. Boeree, Juana Cacho, Violet Chihota, Erica Chimara, Gavin Churchyard, Raquel Cias, Rosa Daza, Charles L. Daley, P.N. Richard Dekhuijzen, Diego Domingo, Francis Drobniewski, Jaime Esteban, Maryse Fauville-Dufaux, Dorte Bek Folkvardsen, Noel Gibbons, Enrique Gómez-Mampaso, Rosa Gonzalez, Harald Hoffmann, Po-Ren Hsueh, Alexander Indra, Tomasz Jagielski, Frances Jamieson, Mateja Jankovic, Eefje Jong, Joseph Keane, Wo-Jung Koh, Berit Lange, Sylvia Leao, Rita Macedo, Turid Mannsåker, Theodore K. Marras, Jeannette Maugein, Heather J. Milburn, Tamas Mlinkó, Nora Morcillo, Kozo Morimoto, Dimitrios Papaventsis, Elia Palenque, Mar Paez-Peña, Claudio Piersimoni, Monika Polanová, Nalin Rastogi, Elvira Richter, Maria Jesus Ruiz-Serrano, Anabela Silva, M. Pedro da Silva, Hulya Simsek, Dick van Soolingen, Nora Szabó, Rachel Thomson, Teresa Tórtola Fernandez, Enrico Tortoli, Sarah E. Totten, Greg Tyrrell, Tuula Vasankari, Miguel Villar, Renata Walkiewicz, Kevin L. Winthrop, Dirk Wagner for the Nontuberculous Mycobacteria Network European Trials Group (NTM-NET)
European Respiratory Journal 2013 42: 1604-1613; DOI: 10.1183/09031936.00149212
Wouter Hoefsloot
1W. Hoefsloot and J. van Ingen share first authorship
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jakko van Ingen
1W. Hoefsloot and J. van Ingen share first authorship
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: j.vaningen@mmb.umcn.nl
Claire Andrejak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristian Ängeby
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosine Bauriaud
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascale Bemer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Beylis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin J. Boeree
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juana Cacho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Violet Chihota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erica Chimara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gavin Churchyard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raquel Cias
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Daza
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles L. Daley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.N. Richard Dekhuijzen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diego Domingo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francis Drobniewski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaime Esteban
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryse Fauville-Dufaux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorte Bek Folkvardsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noel Gibbons
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enrique Gómez-Mampaso
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Gonzalez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harald Hoffmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Po-Ren Hsueh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Indra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomasz Jagielski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frances Jamieson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mateja Jankovic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eefje Jong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Keane
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wo-Jung Koh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Berit Lange
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvia Leao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rita Macedo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Turid Mannsåker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theodore K. Marras
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeannette Maugein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather J. Milburn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamas Mlinkó
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nora Morcillo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kozo Morimoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimitrios Papaventsis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elia Palenque
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mar Paez-Peña
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio Piersimoni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monika Polanová
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nalin Rastogi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elvira Richter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Jesus Ruiz-Serrano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anabela Silva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Pedro da Silva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hulya Simsek
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dick van Soolingen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nora Szabó
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Thomson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Tórtola Fernandez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enrico Tortoli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah E. Totten
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg Tyrrell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tuula Vasankari
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Villar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renata Walkiewicz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin L. Winthrop
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk Wagner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

A significant knowledge gap exists concerning the geographical distribution of nontuberculous mycobacteria (NTM) isolation worldwide.

To provide a snapshot of NTM species distribution, global partners in the NTM-Network European Trials Group (NET) framework (www.ntm-net.org), a branch of the Tuberculosis Network European Trials Group (TB-NET), provided identification results of the total number of patients in 2008 in whom NTM were isolated from pulmonary samples. From these data, we visualised the relative distribution of the different NTM found per continent and per country.

We received species identification data for 20 182 patients, from 62 laboratories in 30 countries across six continents. 91 different NTM species were isolated. Mycobacterium avium complex (MAC) bacteria predominated in most countries, followed by M. gordonae and M. xenopi. Important differences in geographical distribution of MAC species as well as M. xenopi, M. kansasii and rapid-growing mycobacteria were observed.

This snapshot demonstrates that the species distribution among NTM isolates from pulmonary specimens in the year 2008 differed by continent and differed by country within these continents. These differences in species distribution may partly determine the frequency and manifestations of pulmonary NTM disease in each geographical location.

Abstract

Species distribution among nontuberculous mycobacteria isolates from pulmonary specimens is geographically diverse http://ow.ly/npu6r

Introduction

Disease caused by nontuberculous mycobacteria (NTM) has gained increased attention, in part because of an assumed increase in its incidence [1, 2]. With the emergence of case reports and series from diverse countries and regions, it has become clear that the distribution of NTM species that are isolated from clinical samples differs strongly by region [3]. Yet this geographic diversity has never been systemically studied. Increased understanding of this diversity is important, as it can provide important clues on the impact of geographical or climatic differences on NTM distribution and observed discrepancies in clinical relevance and treatment outcome [3, 4]. In this study we have collected pulmonary NTM isolation and identification results from laboratories in different regions in the world, collaborating within the NTM-Network European Trials Group (NET) network (www.ntm-net.org, a branch of the Tuberculosis Network European Trials Group (TB-NET)), from the same time period, to gain further insight on the geographical distribution of NTM species cultured from respiratory samples at a single time point.

Methods

Global partners in the NTM-NET framework were contacted and invited to provide data of the total number of patients from whom NTM were isolated from pulmonary samples in their hospital, regional or reference laboratory in the year 2008, as well as the species identification results and details of the identification methods used. Partners were eligible to contribute to the database if the number of patients with pulmonary NTM isolates per year exceeded 30, to ensure sufficient experience and interpretability of results; one isolate per species per patient was eligible for analysis. We have chosen pulmonary samples in an effort to minimise selection bias. Isolation of NTM from normally sterile sites such as blood or lymph nodes usually indicates definite disease and this may present a strong selection bias, as not all species are equally capable of causing such diseases.

We calculated total number of mycobacteria per continent, the relative contribution of the Mycobacterium avium complex for each continent or country and studied the differences in the relative contribution of other NTM between countries and continents by generating pie-charts. Data of the respondents were plotted on a world map. Since most NTM-NET members are located in Europe, data from European participants were assessed in greater detail, with a focus on north–south differences; we considered Denmark, Norway, Sweden, Finland, the Netherlands, Belgium, Germany, the UK, Ireland and Poland as Northern Europe; all countries to the south of these countries were considered Southern Europe.

Within this study we did not assess the clinical relevance of these isolates. Ethical approval was waived for this retrospective laboratory database study.

Results

Overview

62 centres from 30 countries across six continents participated in this study. 17 national reference laboratories provided data representative for their whole country. For other countries, data was provided by a certain number of laboratories not covering the whole country (see the online supplementary material for details). A total of 20 182 patients had NTM species cultured from pulmonary samples in these centres in 2008; 91.3% (n=18 418) of the isolates were identified to species/complex level; the remaining 1764 isolates (8.7%) were not identified beyond Mycobacterium species other than M. tuberculosis complex. A total of 91 different NTM species were encountered in this survey. The most commonly used identification assays were the GenoType CM/AS (n=28; Hain Lifescience, Nehren, Germany), AccuProbe assays (n=9; Gen-Probe, San Diego, CA, USA), hsp65 PCR-restriction enzyme analysis (PRA) (n=6), Inno-LiPA Mycobacteria v2 (n=3; Innogenetics, Ghent, Belgium), in-house methods (n=6) or combinations thereof; mostly, these were supplemented by 16S rDNA sequencing. The six most frequently isolated NTM were M. avium complex (9421 isolates; 47%), M. gordonae (2170 isolates; 11%), M. xenopi (1605 isolates; 8%), M. fortuitum complex (1322 isolates; 7%), M. abscessus (664 isolates; 3%) and M. kansasii (720 isolates; 4%) (fig. 1). These six species accounted for 80% of all mycobacteria identified.

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Worldwide distribution of different nontuberculous mycobacteria from pulmonary samples in 2008. a) Mycobacterium avium complex; b) M. kansasii; c) M. xenopi; d) M. malmoense; e) M. abscessus; and f) M. fortuitum. Note: the data presented in this figure are not per se representative for each country. Species diversity may differ per country. The exact, per-centre data can be found in the online supplementary material.

A complete overview of all species isolated in all regions is provided in the online supplementary material.

Species isolation worldwide

figure 1 presents the distribution of the most common NTM on a world map. table 1 and figure 2 show data for M. avium complex and other common NTM per continent.

View this table:
  • View inline
  • View popup
Table 1– Distribution of respiratory nontuberculous mycobacteria (NTM) isolates
Figure 2–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2–

Distribution of respiratory nontuberculous mycobacteria (NTM) isolates. MAC: Mycobacterium avium complex; RGM: rapid-growing mycobacteria; SGM: slow-growing mycobacteria.

M. avium complex

The M. avium complex (MAC) species accounted for 9421 (47%) of the 20182 isolates in the study. The highest relative contribution of MAC per continent was found in Australia (71%) and the lowest in South America (31%). Per country, this figure varied from 79% in Japan to 16% in Hungary. 59 out of 62 laboratories were able to identify MAC isolates to species level; the relative frequency of M. intracellulare versus M. avium in different parts of the world is shown in table 1. The most striking difference is the relative predominance, within the participating sites, of M. avium in North- and South America. In contrast, M. intracellulare was most frequent in Australia-Queensland (57% of all mycobacteria cultured and 80% of the MAC) and South Africa (40% of all mycobacteria cultured and 77.5% of the MAC). MAC isolates that were not identifiable to (sub)species level were common in participating laboratories in Asia and Europe (21% and 15% of all MAC isolates, respectively), but relatively rare in the participating laboratories in North America (8%).

M. gordonae

M. gordonae is the second most isolated NTM worldwide in this study, mainly due to a high isolation rate found in Europe, where M. gordonae was the second most isolated NTM. On all other continents, M. gordonae ranked third (North America, South America and Africa) or fourth (Asia and Australia).

M. xenopi

After MAC and M. gordonae, M. xenopi was the third most frequently isolated species in the survey, though its isolation was limited to distinct geographical regions; mainly in Europe and Ontario (eastern Canada) (but not Alberta, western Canada). In Hungary, M. xenopi is the predominant NTM isolate comprising 49% of all the NTM in this country. In Croatia, M. xenopi was the second most frequently isolated NTM after M. gordonae. Furthermore, M. xenopi was prevalent in the English Channel region, being the second most frequent NTM isolate in Belgium and south-east England and ranked third in France after MAC and M. gordonae. Differences within countries were also observed: in Spain, M. xenopi was the predominant NTM isolate in the Barcelona area but only ranked third after MAC and M. fortuitum in the Madrid area. M. xenopi was not isolated in the participating centres from Asia, Australia and South America.

M. kansasii

Overall, M. kansasii was the sixth most frequently isolated NTM. In South America M. kansasii was the second most isolated NTM after MAC, accounting for 19.8% of all NTM isolated. In Europe, Slovakia, Poland and the UK had the highest M. kansasii isolation rates of 36%, 35% and 11%, respectively, compared to a mean isolation rate of 5% in Europe. In the Paris region of France, M. kansasii was the third most isolated NTM after MAC. In the participating laboratory in Japan, M. kansasii ranked fourth after MAC, M. gordonae and M. abscessus. In South Africa, M. kansasii ranked sixth overall. However, in a centre with a large community of miners in the Johannesburg region of South Africa, M. kansasii was the second most frequent NTM isolated.

Rapid growers

M. abscessus and M. fortuitum were the most frequently isolated rapid-growing mycobacteria (RGM) worldwide. Other RGM were only isolated sporadically.

Among the RGM, important geographical differences were observed. RGM were highly prevalent isolates in the participating centres in East Asia, where they make up 27% of all NTM isolates in comparison to isolation frequencies of 17.9%, 16% and 14% in the participating centres in North America, South America and Europe, respectively. However, important differences in frequency of RGM isolation among countries within Asia were also noted. In Tokyo (Japan), rapid growers accounted for only 6.6% of all isolates, in contrast to the participating centres in Taiwan (50%) and South Korea (28.7%). Furthermore, in Taiwan, M. fortuitum and M. abscessus were the second and third most frequently isolated NTM species, while in South Korea M. abscessus was the second most frequently isolated NTM after MAC.

Rare and geographically restricted NTM species

M. malmoense was found more often in Northern Europe (80 (2.6%) out of 3107 isolates); in comparison with Southern Europe (21 (0.6%) out of 3696 isolates). In South Africa, 43 M. malmoense isolates were found (out of 5646; 0.76%). Five M. malmoense isolates from the participating laboratories from North America were reported (five (0.1%) out of 4913 isolates). M. malmoense was not found in Queensland-Australia, Asia and South America. M. simiae was found worldwide except in Asia. A total of 97 patients were found in this study with a M. simiae isolate (0.5% of all 20182 NTM isolated). M. scrofulaceum was the second most isolated NTM in South Africa (383 isolates (6.8%) out of 5646). M. lentiflavum was found in several laboratories worldwide (generally <1% of all NTM isolated per laboratory), but was found more often in Portugal (6%) and Finland (5.8%). The majority of the 91 different NTM species in this study were infrequently isolated, e.g. M. smegmatis (n=5; 0.03%) and M. interjectum (n=36; 0.2%) (online supplementary material).

Focus on Europe

Because of a substantial number of participating countries in Europe, this continent was studied in more detail, with a focus on north–south differences. We collected data of 3107 isolates from Northern Europe and 3696 from Southern Europe. In figure 3, the pie-charts of species diversity in all participating countries in Europe are shown. MAC was isolated more frequently in Northern Europe (44% of all mycobacteria) than in Southern Europe (31%). In both Northern and Southern Europe, M. avium was the most frequent isolated subspecies of the MAC.

Figure 3–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3–

Distribution of different nontuberculous mycobacteria from pulmonary samples in 2008 in Europe. MAC: Mycobacterium avium complex; RGM: rapid-growing mycobacteria; SGM: slow-growing mycobacteria.

M. xenopi was more frequently isolated in Southern (778 (21%) out of 3697 isolates) compared to Northern Europe (190 (6%) out of 3107 isolates), partly due to substantial contribution of M. xenopi isolated in a single country (Hungary). In contrast, M. bohemicum was especially found in Northern Europe, mainly Finland, in contrast to only one isolate from Southern Europe and no isolate from any participating laboratory in other regions of the world.

Discussion

For the first time, we provide a snapshot of the worldwide distribution of NTM species isolated from pulmonary samples. This snapshot illustrates that the species distribution among NTM isolated from pulmonary specimens in the year 2008 differs by region and differs by country within these regions. For many regions or countries that participated in this study, these are the first data covering this topic. The NTM species distribution in a country or region may have profound impact on the frequencies and manifestations of pulmonary NTM disease. It is now generally accepted that NTM species differ in their ability to cause lung disease in humans [3–6] and that the clinical relevance of a particular species can differ in different parts of the world [7, 8]. The species distribution presented in this study can help in identifying factors associated with human NTM infection, such as climate differences, population density or host factors. In the past, it has been suggested that differences in NTM species distribution may also affect the efficacy of bacille Calmette–Guérin vaccination [9].

The two studies that approached this subject were published by MartÍn-Casabona et al. in 2004 [2] and by Marras and Daley in 2002 [3]; the former reported on NTM isolation over three decades, ending in 1996. The spread of molecular tools for identification in the years between 1996 and 2008 make the comparison of the two surveys difficult. The MartÍn-Casabona study only incorporated laboratories from Europe, Turkey, Iran and Brazil and sampling was not systematic as different laboratories produced data from different time periods. The review by Marras and Daley adds more historical published data and is not a survey. Still, both showed the predominance of MAC isolation worldwide, together with the characteristic geographical distribution of M. xenopi, M. kansasii and M. malmoense. The review by Marras and Daley [3] also showed that differences in species distribution may occur over time.

In this study, the members of the M. avium complex predominated in most regions, though M. xenopi predominated in Hungary and M. kansasii in Poland and Slovakia. The relative distribution of the various members of MAC again reveals geographic differences. While M. avium predominated in the participating centres in North and South America and Europe, M. intracellulare was most frequently isolated in South Africa and Australia. In Australia a significant increase in the isolation of this species has been reported before [5]. Few laboratories were able to reliably distinguish the novel MAC members, such as M. colombiense and M. chimaera [10, 11].

M. xenopi was particularly prevalent in the region covering Hungary, Croatia, Northern Italy, in Ontario-Canada and in the areas bordering the English Channel; the latter two are in line with earlier data [1, 2]. The frequently stated link to coastal areas [1, 2, 12] does not hold true in the light of the observed predominance in Hungary and its absence in coastal regions outside Europe. Nonetheless, the presence of a specific environmental niche for M. xenopi is a likely explanation. Other factors to be considered are differences in the potential to colonise or infect human airways between M. xenopi strains and host factors.

The geographical distribution of M. kansasii has been the subject of previous studies. In our study, M. kansasii was frequently isolated in South America, Eastern Europe and the metropolitan centres of Paris, London and Tokyo and the Johannesburg region of South Africa. These findings match previously published data from those regions [2, 8]. Its isolation has been related to mining activities [13–15] as well as urbanisation and may be related to working and living conditions [16]. In Northern Europe, isolation frequencies of M. kansasii have been in decline for the past three decades [17], but the underlying causes are unknown. The high isolation frequency of M. scrofulaceum in South Africa is in accordance with the literature and probably related to mining activities [15].

M. simiae was traditionally thought to be confined to the Southern USA, Cuba and Israel [7], but in this study we demonstrate that this species has a global distribution (except in Asia), making up 0.67% of all isolates in this study, with the highest isolation of 1.1% found in Northern Europe. M. malmoense was found especially in Northern Europe, which is in accordance with the literature [8], but also in South Africa. M. malmoense isolation from clinical specimens from this continent has never been reported before, although its presence in soil has been reported [18].

RGM made up 10–20% of all NTM isolates worldwide, although they proved more prevalent in East Asia where they compose up to 50% (Taiwan) of all NTM isolated from pulmonary samples. The high isolation frequency of RGM, particularly M. abscessus, was also noted in previous studies focusing on this region [19–21]. The reason for the high isolation rate of RGM in Asian countries remains unclear, although geographical or climatic factors, host and laboratory factors have been suggested [20]. An important reason to perform studies on the geographical distribution of NTM is to help identify factors associated with differences in worldwide isolation patterns of specific species. Studies focusing on species-specific environmental niches and subsequent transmission to humans are not systematically performed. Yet these could offer important clues that would be of aid to prevent (re)infection of susceptible patients.

In the current study, a multitude of molecular identification techniques was used. It is well known that these techniques can produce discrepant results [22, 23]. Yet this is likely to influence a minority of isolates and will not affect the snapshot of the geographic diversity in NTM species isolated from pulmonary samples, as presented in this study. The current study revealed the occasional presence of many rare species (online supplementary data). For many of these species no data other than reports of single cases of disease were available. Often such case reports or novel species descriptions seem to suggest a very limited geographic spread of the bacterium and, as they mostly concern cases of true disease, overestimate the clinical relevance of these rare species. We hope that the current study also provides a reference to clinicians and microbiologists faced with rare NTM species.

An important shortcoming of this study is the low number of participating laboratories, especially outside Europe. Inclusion of more data from different laboratories will probably reveal other isolation patterns.

Follow-up studies covering different time periods together with more participating laboratories may reveal additional clues on changing NTM pattern over time and geographic differences of NTM distribution on the national scale.

We have chosen pulmonary samples specifically because these best reflect the distribution of species in local environments. Nevertheless, presence and persistence within the human airways is also likely to represent a selection bias, as does the fact that we collected identification results of cultured isolates. The low isolation frequency of the majority of the 91 different NTM species may reflect an inability to persist in human airways or a scarce environmental presence.

In summary, this snapshot illustrates that the species distribution among NTM isolated from pulmonary specimens in the year 2008 differs by region and differs by country within these regions. MAC predominates in most settings, but the frequency of isolation of RGM, or slow growers like M. xenopi, M. kansasii and M. malmoense differs per setting. These differences in species distribution may determine, in part, the frequency and manifestations of pulmonary NTM disease in each region. Future studies need to address species-specific environmental niches as a cause of differences in worldwide isolation patterns.

Acknowledgments

The authors’ affiliations are as follows. W. Hoefsloot: Dept of Pulmonary Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; J. van Ingen: Dept of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; C. Andrejak: Respiratory Diseases Dept, Amiens Teaching Hospital, Amiens, France; K. Ängeby: Dept of Clinical Microbiology, Karolinska Institute, Stockholm, Sweden; R. Bauriaud: Laboratoire Central de Microbiologie, Hôpital Purpan, Toulouse, France; P. Bemer: Service de Bacteriologie-Hygiene, CHU de Nantes, Institut de Biologie, Nantes, France; N. Beylis: National Health Laboratory Service, Braamfontein, South Africa; M.J. Boeree: Dept of Pulmonary Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; J. Cacho: Dept of Microbiology, University Hospital of Getafe, Getafe, Madrid, Spain; V. Chihota: The Aurum Institute for Health Research, Johannesburg, South Africa; E. Chimara: Setor de Micobactérias, Seção de Bacteriologia, Instituto Adolfo Lutz, São Paulo, Brazil; G. Churchyard: The Aurum Institute for Health Research, Johannesburg, South Africa; R. Cias: Dept of Clinical Microbiology, Hospital Clinico San Carlos, Madrid, Spain; R. Daza: Dept of Microbiology, Hospital Universitario Puerta de Hierro, Madrid, Spain; C.L. Daley: Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, CO, USA; P.N.R. Dekhuijzen: Dept of Pulmonary Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; D. Domingo: Dept of Microbiology, Hospital Universitario de la Princesa, Madrid, Spain; F. Drobniewski: UK Health Protection Agency National Mycobacterium Reference Laboratory, London, UK; J. Esteban: Dept of Clinical Microbiology. IIS-Fundación Jiménez Díaz, Madrid, Spain; M. Fauville-Dufaux: National Reference Centre of Tuberculosis and Mycobacteria, Scientific Institute of Public Health, Brussels, Belgium; D.B. Folkvardsen: International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark; N. Gibbons: St. James's Hospital and Trinity College Dublin, Dublin, Ireland; E. Gómez-Mampaso: Hospital Ramon y Cajal, Madrid, Spain; R. Gonzalez: Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain; H. Hoffmann: Institute of Microbiology and Laboratory Medicine, Supranational Reference Laboratory, Asklepios Fachkliniken, Gauting, Germany; P.R. Hsueh: Departments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; A. Indra: Austrian Agency for Health and Food Safety, Vienna, Austria; T. Jagielski: Dept of Applied Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland; F. Jamieson: Clinical and Environmental Microbiology, Public Health Laboratories Branch, Ontario Ministry of Health and Long-Term Care, Toronto, Canada; M. Jankovic: Dept of Respiratory Diseases, University Hospital Centre, University of Zagreb Medical School, Zagreb, Croatia; E. Jong: Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; J. Keane: St. James's Hospital Dublin, and Trinity College Dublin, Dublin, Ireland; W.J. Koh: Division of Pulmonary and Critical Care Medicine, Dept of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; B. Lange: Centre for Infectious Diseases and Travel Medicine, University Hospital Freiburg, Freiburg, Germany; S. Leao: Disciplina de Microbiologia, Dept de Microbiologia, Imunologia e Parasitologia da Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil; R. Macedo: Public Health Laboratory: Mycobacteriology/Tuberculosis, Public Health Dept, Administração Regional de Saúde de Lisboa e Vale do Tejo, Lisbon, Portugal; T. Mannsåker: Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway; T.K. Marras: Joint Division of Respirology, University Health Network and Mount Sinai Hospital, Dept of Medicine, University of Toronto, Toronto, Canada; J. Maugein: Laboratoire de Bactériologie, Université Victor Segalen Bordeaux, Bordeaux, France; H.J. Milburn: Dept of Respiratory Medicine, Guy’s and St Thomas’ NHS Foundation Trust, London, UK; T. Mlinkó: Koranyi National Institute for Tuberculosis and Pulmonology, Budapest, Hungary; N. Morcillo: Laboratorio de Referencia del Programa de Control de la Tuberculosis de la Provincia de Buenos Aires, Hospital Dr. Antonio Cetrángolo, Buenos Aires, Brazil; K. Morimoto: Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan; D. Papaventsis: National Mycobacteria Reference Laboratory, Sotiria Chest Diseases Hospital, Athens, Greece; E. Palenque: Dept of Microbiology, Hospital 12 de Octubre, Madrid, Spain; M. Paez-Peña: Hospital Severo Ochoa, Madrid, Spain; C. Piersimoni: Regional Reference Mycobacteria Laboratory, United Hospitals, Ancona, Italy; M. Polanová: The National Institute of TB, Respiratory Diseases and Chest Surgery, Vyšne Hágy, Slovakia; N. Rastogi: WHO Supranational TB Reference Laboratory, Unité de la Tuberculose et des Mycobactéries, Institut Pasteur de Guadeloupe, Abymes, Guadeloupe, France; E. Richter: National Reference Centre for Mycobacteria, Borstel, Germany; M.J. Ruiz-Serrano: Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital Gregorio Marañón, Madrid, Spain; A. Silva: General Directorate of Health in Lisbon and Lung Diseases Centre of Venda Nova, Amadora, Portugal; M.P. da Silva: University of the Witwatersrand, Johannesburg, and National Health Laboratory Services, Braamfontein, South Africa; H. Simsek: Refik Saydam National Public Health Agency, National Tuberculosis Reference Laboratory, Ankara, Turkey; D. van Soolingen: National Institute for Public Health and the Environment, Bilthoven, the Netherlands; N. Szabó: Korányi National Institute for Tuberculosis and Respiratory Medicine, Budapest, Hungary; R. Thomson: Gallipoli Medical Research Centre, Greenslopes Private Hospital, Brisbane, Australia; T. Tórtola Fernandez: Hospital Val d’Hebron, Barcelona, Spain; E. Tortoli: Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan, Italy; S.E. Totten: Dept of Mycobacteriology, Advanced Diagnostics Laboratories, National Jewish Health, Denver, CO, USA; G. Tyrrell: Provincial Laboratory for Public Health, University of Calgary, Calgary, Canada; T. Vasankari: Epidemiologic Surveillance and Response Unit, Dept of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland; M. Villar: General Directorate of Health in Lisbon and Lung Diseases Centre of Venda Nova, Amadora, Portugal; R. Walkiewicz: Dept of Internal Medicine, Pneumology and Allergology, Medical University of Warsaw, Warsaw, Poland; K. Winthrop: Division of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR, USA; D. Wagner: Dept of Internal Medicine II – Infectious Diseases, University of Freiburg, Freiburg, Germany.

The following persons contributed to the data collection in Italy: Danila Costa (Bari), Marco Arosio (Bergamo), Concetta Mazza (Bologna), Eliana Frizzera (Bolzano), Marina Matteucci (Forlì-Cesena), Ester Mazzola (Milano), Giulia Santoro (Napoli), Gian Lorenzo Molinari (Novara), Patrizia Chiaradonna (Roma) and Claudio Scarparo (Udine).

The authors are responsible for the contents of the publication.

Footnotes

  • This article has supplementary material available from www.erj.ersjournals.com

  • Support statement: This study was supported by the German Federal Ministry of Education and Research (BMBF 01 EO 0803).

  • Conflict of interest: None declared.

  • Received September 19, 2012.
  • Accepted January 18, 2013.
  • ©ERS 2013

References

  1. ↵
    1. Marras TK,
    2. Chedore P,
    3. Ying AM,
    4. et al
    . Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003. Thorax 2007; 62: 661–666.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Martín-Casabona N,
    2. Bahrmand AR,
    3. Bennedsen J,
    4. et al
    . Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 2004; 8: 1186–1193.
    OpenUrlPubMedWeb of Science
  3. ↵
    1. Marras TK,
    2. Daley CL
    . Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002; 23: 553–567.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. van Ingen J,
    2. Bendien SA,
    3. de Lange WC,
    4. et al
    . Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, the Netherlands. Thorax 2009; 64: 502–506.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Thomson RM
    . Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 2010; 16: 1576–1583.
    OpenUrlCrossRefPubMed
  6. ↵
    The Mycobacteriosis Research Group of the Japanese National Chest Hospitals. Rapid increase of the incidence of lung disease due to Mycobacterium kansasii in Japan. Chest 1983; 83: 890–892.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Griffith DE,
    2. Aksamit T,
    3. Brown-Elliot BA,
    4. et al
    . An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367–416.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Hoefsloot W,
    2. Boeree MJ,
    3. van Ingen J,
    4. et al
    . The rising incidence and clinical relevance of Mycobacterium malmoense. Int J Tuberc Lung Dis 2008; 12: 987–993.
    OpenUrlPubMedWeb of Science
  9. ↵
    1. Black GF,
    2. Dockrell HM,
    3. Crampin AC,
    4. et al
    . Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis 2001; 184: 322–329.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Murcia MI,
    2. Tortoli E,
    3. Menendez MC,
    4. et al
    . Mycobacterium colombiense sp. nov., a novel member of the Mycobacterium avium complex and description of MAC-X as a new ITS genetic variant. Int J Syst Evol Microbiol 2006; 56: 2049–2054.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Tortoli E,
    2. Rindi L,
    3. Garcia MJ,
    4. et al
    . Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int J Syst Evol Microbiol 2004; 54: 1277–1285.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Dailloux M,
    2. Abalain ML,
    3. Laurain C,
    4. et al
    . Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 2006; 28: 1211–1215.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Corbett EL,
    2. Blumberg L,
    3. Churchyard GJ,
    4. et al
    . Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999; 160: 15–21.
    OpenUrlCrossRefPubMedWeb of Science
    1. Chobot S,
    2. Malis J,
    3. Sebáková H,
    4. et al
    . Endemic analysis of infections caused by Mycobacterium kansasii in the Karviná district in 1968–1995: an analysis of epidemiological data. Cent Eur J Public Health 1997; 5: 164–173.
    OpenUrlPubMed
  14. ↵
    1. Corbett EL,
    2. Hay M,
    3. Churchyard GJ,
    4. et al
    . Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberc Lung Dis 1999; 3: 501–507.
    OpenUrlPubMed
  15. ↵
    1. Bloch KC,
    2. Zwerling L,
    3. Pletcher MJ,
    4. et al
    . Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 1998; 129: 698–704.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. van Ingen J,
    2. Wagner D
    . Epidemiologie der nichttuberkulösen mykobakteriellen Erkrankungen in Deutschland und weltweit [The epidemiology of nontuberculous mycobacterial disease in Germany and worldwide]. Pneumologe 2011; 8: 396–403.
    OpenUrlCrossRef
  17. ↵
    1. Portaels F,
    2. Larsson L,
    3. Jenkins PA
    . Isolation of Mycobacterium malmoense from the environment in Zaire. Tuber Lung Dis 1995; 76: 160–162.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Koh WJ,
    2. Kwon OJ,
    3. Jeon K,
    4. et al
    . Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006; 129: 341–348.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Simons SO,
    2. van Ingen J,
    3. Hsueh PR,
    4. et al
    . Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis 2011; 17: 343–349.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Chen CY,
    2. Chen HY,
    3. Chou CH,
    4. et al
    . Pulmonary infection caused by nontuberculous mycobacteria in a medical center in Taiwan, 2005–2008. Diagn Microbiol Infect Dis 2012; 72: 47–51.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Tortoli E,
    2. Bartoloni A,
    3. Böttger EC,
    4. et al
    . Burden of unidentifiable mycobacteria in a reference laboratory. J Clin Microbiol 2001; 39: 4058–4065.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. van Ingen J,
    2. de Zwaan R,
    3. Enaimi M,
    4. et al
    . Re-analysis of 178 previously unidentifiable Mycobacterium isolates in the Netherlands in 1999–2007. Clin Microbiol Infect 2010; 16: 1470–1474.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 42 Issue 6 Table of Contents
European Respiratory Journal: 42 (6)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
Wouter Hoefsloot, Jakko van Ingen, Claire Andrejak, Kristian Ängeby, Rosine Bauriaud, Pascale Bemer, Natalie Beylis, Martin J. Boeree, Juana Cacho, Violet Chihota, Erica Chimara, Gavin Churchyard, Raquel Cias, Rosa Daza, Charles L. Daley, P.N. Richard Dekhuijzen, Diego Domingo, Francis Drobniewski, Jaime Esteban, Maryse Fauville-Dufaux, Dorte Bek Folkvardsen, Noel Gibbons, Enrique Gómez-Mampaso, Rosa Gonzalez, Harald Hoffmann, Po-Ren Hsueh, Alexander Indra, Tomasz Jagielski, Frances Jamieson, Mateja Jankovic, Eefje Jong, Joseph Keane, Wo-Jung Koh, Berit Lange, Sylvia Leao, Rita Macedo, Turid Mannsåker, Theodore K. Marras, Jeannette Maugein, Heather J. Milburn, Tamas Mlinkó, Nora Morcillo, Kozo Morimoto, Dimitrios Papaventsis, Elia Palenque, Mar Paez-Peña, Claudio Piersimoni, Monika Polanová, Nalin Rastogi, Elvira Richter, Maria Jesus Ruiz-Serrano, Anabela Silva, M. Pedro da Silva, Hulya Simsek, Dick van Soolingen, Nora Szabó, Rachel Thomson, Teresa Tórtola Fernandez, Enrico Tortoli, Sarah E. Totten, Greg Tyrrell, Tuula Vasankari, Miguel Villar, Renata Walkiewicz, Kevin L. Winthrop, Dirk Wagner
European Respiratory Journal Dec 2013, 42 (6) 1604-1613; DOI: 10.1183/09031936.00149212

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
Wouter Hoefsloot, Jakko van Ingen, Claire Andrejak, Kristian Ängeby, Rosine Bauriaud, Pascale Bemer, Natalie Beylis, Martin J. Boeree, Juana Cacho, Violet Chihota, Erica Chimara, Gavin Churchyard, Raquel Cias, Rosa Daza, Charles L. Daley, P.N. Richard Dekhuijzen, Diego Domingo, Francis Drobniewski, Jaime Esteban, Maryse Fauville-Dufaux, Dorte Bek Folkvardsen, Noel Gibbons, Enrique Gómez-Mampaso, Rosa Gonzalez, Harald Hoffmann, Po-Ren Hsueh, Alexander Indra, Tomasz Jagielski, Frances Jamieson, Mateja Jankovic, Eefje Jong, Joseph Keane, Wo-Jung Koh, Berit Lange, Sylvia Leao, Rita Macedo, Turid Mannsåker, Theodore K. Marras, Jeannette Maugein, Heather J. Milburn, Tamas Mlinkó, Nora Morcillo, Kozo Morimoto, Dimitrios Papaventsis, Elia Palenque, Mar Paez-Peña, Claudio Piersimoni, Monika Polanová, Nalin Rastogi, Elvira Richter, Maria Jesus Ruiz-Serrano, Anabela Silva, M. Pedro da Silva, Hulya Simsek, Dick van Soolingen, Nora Szabó, Rachel Thomson, Teresa Tórtola Fernandez, Enrico Tortoli, Sarah E. Totten, Greg Tyrrell, Tuula Vasankari, Miguel Villar, Renata Walkiewicz, Kevin L. Winthrop, Dirk Wagner
European Respiratory Journal Dec 2013, 42 (6) 1604-1613; DOI: 10.1183/09031936.00149212
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Article

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Social consequences of sleep disordered breathing
  • Diagnosing airflow obstruction in COPD
Show more Original Article

Respiratory Infections

  • Role of non-pharmaceutical interventions in bronchiolitis outbreaks
  • In critically ill patients, anti-anaerobic antibiotics increase risk of adverse outcomes
  • Biomarker assay to risk-stratify patients with respiratory tract infection
Show more Respiratory Infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society